Isorhamnetin: what is the in vitro evidence for its antitumor potential and beyond?
Lei J, Yang J, Bao C, Lu F, Wu Q, Wu Z, Lv H, Zhou Y, Liu Y, Zhu N, Yu Y, Zhang Z, Hu M, Lin L.
Lei J, et al. Among authors: lu f.
Front Pharmacol. 2024 Apr 8;15:1309178. doi: 10.3389/fphar.2024.1309178. eCollection 2024.
Front Pharmacol. 2024.
PMID: 38650631
Free PMC article.
Review.